Characteristics, Clinical Differences and Outcomes of Breast Cancer Patients with Negative or Low HER2 Expression
{{output}}
Background: High expression of HER2 receptor in Immunohistochemistry (IHC) sections or amplification of its gene in In Situ Hybridization (ISH) assays define a subset of breast cancers that have an aggressive natural history but ... ...
